Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT

Journal of the Neurological Sciences

Volumn 281, Issue 1-2, 2009, Pages 93-98

  Kimura, Noriyuki ^a   Kumamoto, Toshihide ^a   Masuda, Teruaki ^a   Nomura, Yuki ^a   Hanaoka, Takuya ^a   Hazama, Yusuke ^a   Okazaki, Toshio ^a   Arakawa, Ryuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

3DSRT; Brain perfusion SPECT; eZIS; Spinocerebellar degeneration; Thyrotropin releasing hormone

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; PROTIRELIN;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER PROGRAM; FEMALE; HUMAN; INTERNATIONAL COOPERATIVE ATAXIA RATING SCALE; MALE; PRIORITY JOURNAL; RATING SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINOCEREBELLAR DEGENERATION; TREATMENT DURATION;

AGED; AUTOMATIC DATA PROCESSING; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HORMONES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SPINOCEREBELLAR DEGENERATIONS; THYROTROPIN-RELEASING HORMONE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 67349092410     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.01.023     Document Type: Article

References (31)

1. Morley J.E. Extrahypothalamic thyrotropin releasing hormone (TRH) - its distribution and its functions. Life Sci 25 (1979) 1539-1550
2. Tanaka K., Ogawa N., Asanuma M., and Kondo Y. Thyrotropin releasing hormone prevents abnormalities of cortical acetylcholine and monoamines in mice following head injury. Regul Pept 18 (1997) 173-178
3. Yoshinari S., Hamano S., Tanaka M., and Minamitani M. Alteration of regional cerebral blood flow to thyrotropin-releasing hormone therapy in acute encephalitis and encephalopathy during childhood. Eur J Paediatr Neurol 10 (2006) 124-128
4. Nakamura R., and Fujita M. Effect of thyrotropin-releasing hormone (TRH) on motor performance of hemiparetic stroke patients. Tohoku J Exp Med 160 (1990) 141-143
5. Luo L., Yano N., Mao Q., Jackson I.M., and Stopa E.G. Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. J Alzheimers Dis 4 (2002) 97-103
6. Takeuchi Y., Miyanomae Y., Komatsu H., Oomizono Y., Nishimura A., Okano S., et al. Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy. J Child Neurol 9 (1994) 287-289
7. Sobue I., Yamamoto H., Konagaya M., Iida M., and Takayanagi T. Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration. Lancet 1 (1980) 418-419
8. Sobue I., Takayanagi T., Nakanishi T., Tsubaki T., Uono M., Kinoshita M., et al. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations. J Neurol Sci 61 (1983) 235-248
9. Izumi Y., Fukuuchi Y., Ishihara N., Imai A., and Komatsumoto S. Effect of thyrotropin-releasing hormone (TRH) on cerebral blood flow in spinocerebellar degeneration and cerebrovascular disease. Tokai J Exp Clin Med 20 (1995) 203-208
10. Waragai M., Yamada T., and Matsuda H. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases. J Neurol Sci 260 1-2 (2007) 57-64
11. Matsuda H., Mizumura S., Nagao T., Ota T., Iizuka T., Nemoto K., et al. Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol 28 (2007) 731-736
12. Takeuchi R., Sengoku T., and Matsumura K. Usefulness of fully automated constant ROI analysis software for the brain: 3DSRT and FineSRT. Radiat Med 24 (2006) 538-544
13. Tateno M., Utsumi K., Kobayashi S., Takahashi A., Saitoh M., Morii H., et al. Usefulness of a blood flow analyzing program 3DSRT to detect occipital hypoperfusion in dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1206-1209
14. Waragai M., Ogawara K., Takaya Y., and Hayashi M. Efficacy of TRH-T for spinocerebellar degeneration - the relation between clinical features and effect of TRH therapy. Clin Neurol 37 (1997) 587-594
15. Trouillas P., Takayanagi T., Hallett M., Currier R.D., Subramony S.H., Wessel K., et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145 (1997) 205-211
16. Matsuda H., Tsuji S., Shuke N., Sumiya H., Tonami N., and Hisada K. Noninvasive measurements of regional cerebral blood flow using technetium-99 m hexamethylpropylene amine oxime. Eur J Nucl Med 20 (1993) 391-401
17. Matsuda H., Yagishita A., Tsuji S., and Hisada K. A quantitative approach to technetium-99 m ethyl cysteinate dimer: a comparison with technetium-99 m hexamethylpropylene amine oxime. Eur J Nucl Med 22 (1995) 633-637
18. Lassen N.A., Andersen A.R., Friberg L., and Paulson O.B. The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 8 (1988) S13-S22
19. Friberg L., Andersen A.R., Lassen N.A., Holm S., and Dam M. Retention of 99mTc-bicisate in the human brain after intracarotid injection. J Cereb Blood Flow Metab 14 (1994) S19-S27
20. Honjo K., Ohshita T., Kawakami H., Naka H., Imon Y., Maruyama H., et al. Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6. Arch Neurol 61 (2004) 933-937
21. De Michele G., Mainenti P.P., Soricelli A., et al. Cerebral blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. J Neurol 245 (1998) 603-608
22. LeWitt P.A., and Ehrenkranz J.R.L. TRH and spinocerebellar degeneration. Lancet 2 (1982) 981
23. Hökfelt T., Fuxe K., Johansson O., Jeffcoate S., and White N. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol 34 2 (1975) 389-392
24. Kubek M.J., Lorincz M.A., and Wilber J.F. The identification of thyrotropin releasing hormone (TRH) in hypothalamic and extrahypothalamic loci of the human nervous system. Brain Res 126 (1977) 196-200
25. Oturai P.S., Friberg L., Sam I., and Perrild H. Effects of thyrotropin-releasing hormone on regional cerebral blood flow in man. Acta Endocrinol (Copenh) 126 3 (1992) 243-246
26. Koskinen L.O. Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows. Br J Pharmaco 87 (1986) 509-519
27. Rouiller E.M., Liang F., Babalian A., Moret V., and Wiesendanger M. Cerebellothalamocortical and pallidothalamocortical projections to the primary and supplementary motor cortical areas: a multiple tracing study in macaque monkeys. J Comp Neurol 345 (1994) 185-213
28. Koskinen L.O., and Bill A. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit. Acta Physiol Scand 122 (1984) 127-136
29. Koskinen L.O. Effects of TRH on cerebral and peripheral blood flows; role of submesencephalic brain stem centres. Acta Physiol Scand 128 2 (Oct 1986) 277-288
30. Yarbrough G.G. On the neuropharmacology of thyrotropin releasing hormone (TRH). Prog Neurobiol 12 (1979) 291-312
31. Inanami O., Meguro K., Ohno K., and Sato A. Contribution of cholinergic vasodilators on the increase in cerebral cortical blood flow responses to the intravenous administration of thyrotropin releasing hormone in anesthetized rats. Neurosci Lett 88 (1988) 184-188